Zimbabwe has turned down a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential biological samples.
This rejection became public following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesperson has since explained that the United States was requesting health data for research and profit but refused to guarantee the benefits from any future vaccines.
"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged more talks to find a deal acceptable to all parties so the country's vital HIV programme can be sustained.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a court blocked a similar health funding agreement following concerns were filed about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
Based on reports, Sixteen nations in Africa have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be available to our population should a future pandemic arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks already established through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This framework is designed to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We welcome further dialogue with our American counterparts on how future co-operation could be structured in a manner that respects the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but suggested that negotiations must proceed considering a large portion of the country's HIV programmes depended on foreign aid.
"If technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
This impasse underscores the ongoing challenges between accepting crucial foreign assistance and safeguarding a country's data in an increasingly data-driven world.